FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Road to Brexit
Economy
The Trump Effect
Detained in Myanmar
Environment
Sport
Royal Wedding
Lifestyle
Healthcare
January 31, 2018 / 1:36 PM / 3 months ago

BRIEF-Parenteral Drugs India Gets Shareholders' Nod For Sale Of Shares In Infutec Healthcare

Reuters Staff

1 Min Read

Jan 31 (Reuters) - Parenteral Drugs India Ltd:

* GETS SHAREHOLDERS’ NOD FOR SALE OF KASRAWAD UNDERTAKING AND WFI UNDERTAKING OF CO TO INFUTEC HEALTHCARE

* GETS SHAREHOLDERS' NOD FOR SALE OF SHARES IN INFUTEC HEALTHCARE Source text: bit.ly/2nsa1b9 Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.